Apr 09,2026
April 9, 2026
The 1st CPIC Global Conference on Innovative Drugs 2026 will kick off grandly at the National Exhibition and Convention Center (Shanghai) from July 22 to 24. This is a premier event focused on the globalization of China's innovative drugs, and an open platform for gathering industry wisdom, showcasing cutting-edge achievements, and connecting industrial resources.
Starting today, the conference officially opens the following calls for global biopharmaceutical professionals:
China’s Original “Nuclear” Power Is Rising
Apr 07,2026
The "China Storm" in the Radiopharmaceutical Sector
Apr 06,2026
DRAGONHEART has officially become the Cultural Strategic Partner of the 1st China Pharmaceutical Innovation Conference. Liu Dali, Founder of DRAGONHEART and Chairman of the Hong Kong Professional Listing and Overseas Go-Listing Service Alliance, has been invited to serve as Co-Chair of the conference organizing committee.
A+H: Chinese Biotech Accelerates Its “Dual-Listing” Strategy
Apr 06,2026
The tide of "A+H" is rising
Chinese Innovative Drugs Return to the M&A Arena
Apr 05,2026
The tide will rise again in 2026
On March 31, two industry giants simultaneously announced acquisition deals: Eli Lilly agreed to acquire sleep-disorder drug company Centessa Pharmaceuticals for up to $7.8 billion, while Biogen shelled out $5.6 billion to acquire Apellis Pharmaceuticals, a developer of immunology and rare-disease therapeutics.
China’s AI-Driven Pharmaceutical Industry Reveals Its “Weight-Loss Ace”
Apr 03,2026
The Race for the Next “Blockbuster King”
Follow or Contact Us
Follow the TONACEA Official WeChat Account and scan the QR code to register. Stay updated with the latest conference news.
Public Account QR Code
Registration QR Code
Conference Service Hotline
© 2026 TONACEA (Shanghai) Technology Development Co., Ltd. All rights reserved. All rights reserved.
